Company intelligence / Profile preview

SmartPack

Ownership: Private
Development stage: Commercial

Overview

SmartPak is a patented dual-bag sterile packaging system for injectable antibiotics such as cefazolin, cefoxitin, ceftriaxone, cefepime and vancomycin. It is designed to improve efficiency and safety in hospital and compounding pharmacy settings by reducing manual manipulations during drug reconstitution and syringe filling. The system has been positively received for its ease of use and ability to reduce contamination risk[4][5][6][7].

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeAntibiotic
Industry: Therapeutic Medical Devices

Partnerships

none disclosed

Beyond the preview

Go deeper on SmartPack.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SmartPack.

Explore the full profile